2nd Quarter - Report

DUTKO WORLDWIDE, LLC for BIOGENIDEC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Monitoring federal legislation related to Patent Reform Act of 2007 (HR1908/S1145) and other health care issues and advise client as it affects them.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Executive Office of the President (EOP)

Bills named: H.R. 1908 (110th)

Health Issues HCR

Monitoring implementation and legislation affecting the Medicare program, the Prescription Drug User Fee Act, legislation to create a regulatory pathway for biosimiliars (Pathway for Biosimilars Act (H.R. 5629)) and other major health care initiatives before Congress.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS)

Bills named: H.R. 5629 (110th)

Medicare/Medicaid MMM

Monitoring implementation and legislation affecting the Medicare program, the Prescription Drug User Fee Act, legislation to create a regulatory pathway for biosimiliars (Pathway for Biosimilars Act (H.R. 5629)) and other major health care initiatives before Congress.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); Commerce, Dept of (DOC)

Bills named: H.R. 5629 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.